Results 261 to 270 of about 449,883 (300)
Some of the next articles are maybe not open access.
Pindolol for ventricular arrhythmia
American Heart Journal, 1982The role of pindolol in treating ventricular arrhythmia was studied in 43 patients with this disorder. Of these patients, 23 had coronary heart disease, 5 had valvular disease, and 15 had no demonstrable heart disease. patients underwent acute drug testing with 20 mg pindolol (phase 1) followed by maintenance therapy (phase 2) for 3 days (20 to 80 mg ...
P J, Podrid, B, Lown
openaire +2 more sources
Ablation of ventricular arrhythmias
Trends in Cardiovascular Medicine, 2014Ventricular arrhythmias (VAs) commonly occur in patients with structural heart disease and may present as ventricular premature depolarizations (VPDs), monomorphic ventricular tachycardia (VT), or polymorphic VT/ventricular fibrillation. Idiopathic VAs can also occur in patients with normal hearts.
Mouhannad M, Sadek +1 more
openaire +2 more sources
Mapping of Ventricular Arrhythmias
Cardiology Clinics, 1986Mapping of ventricular arrhythmias is essential for their reliable surgical and ablative management. Activation mapping is the most widely used technique but demands induction of the arrhythmia. Mapping strategies that can identify an arrhythmogenic substrate in sinus rhythm are clinically attractive but require further investigation before their ...
openaire +2 more sources
Genetic Basis of Ventricular Arrhythmias
Cardiology Clinics, 2008Sudden cardiac death caused by malignant ventricular arrhythmias is the most important cause of death in the industrialized world. Most of these lethal arrhythmias occur in the setting of ischemic heart disease. A significant number of sudden deaths, especially in young individuals, are caused by inherited ventricular arrhythmic disorders, however ...
Boussy, Tim +7 more
openaire +7 more sources
Surgery for ventricular arrhythmia
The Annals of Thoracic Surgery, 1990Years of frustration of cardiac surgeons attempting to control intractable ventricular arrhythmia finally ended when the team of Harken, Josephson, and Horowitz performed electrophysiologically directed left ventricular endocardial resection and reported their early results 10 years ago.
openaire +2 more sources
Postgraduate Medicine, 1991
Patients with asymptomatic ventricular premature complexes who do not have evidence of heart disease should not be treated with either class I or class III (Vaughan Williams) antiarrhythmic drugs. Patients who are symptomatic may be given beta blockers.
openaire +2 more sources
Patients with asymptomatic ventricular premature complexes who do not have evidence of heart disease should not be treated with either class I or class III (Vaughan Williams) antiarrhythmic drugs. Patients who are symptomatic may be given beta blockers.
openaire +2 more sources
TREATMENT OF VENTRICULAR ARRHYTHMIAS
The Lancet, 1972J R, Wagner, A R, Hunter
openaire +2 more sources
Lidocaine in ventricular arrhythmia
American Heart Journal, 1973J P, Liss, R M, Jeresaty, J, Nakhoul
openaire +2 more sources
Abstract This chapter focuses on ventricular arrhythmia. Content is mapped to the ESC Core Curriculum and is ideal for candidates preparing to take the European Exam in Core Cardiology (EECC). To ensure effective revision, material is presented in short sections with bullet lists, tables, and boxes to highlight key facts.
Richard Bond, Howell Williams
openaire +1 more source
Richard Bond, Howell Williams
openaire +1 more source
Lidocaine and Ventricular Arrhythmias
New England Journal of Medicine, 1968G, Härtel, P, Karhunen
openaire +2 more sources